首页> 美国卫生研究院文献>Hepatitis Monthly >Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population
【2h】

Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population

机译:缺乏维生素K或拮抗剂II(PIVKA-II)诱导的蛋白在中国人群肝细胞癌筛查中的表现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Alpha-fetoprotein (AFP) has long been used as an effective biomarker for hepatocellular carcinoma (HCC) screening; however, not all HCC patients can be detected with an elevated AFP level, especially in early HCC patients. Protein Induced by vitamin K absence or antagonist-II (PIVKA-II) is another serum biomarker linked to HCC; however, sensitivity and specificity remain controversial and data in Chinese groups is even rarer.
机译:背景:甲胎蛋白(AFP)长期以来一直被用作肝细胞癌(HCC)筛查的有效生物标志物。但是,并非所有HCC患者都能检测到AFP水平升高,尤其是在早期HCC患者中。缺乏维生素K或拮抗剂II(PIVKA-II)诱导的蛋白质是与HCC相关的另一种血清生物标志物。然而,敏感性和特异性仍存在争议,中国人群的数据更为罕见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号